VC-backed Otonomy raises $100 mln for IPO

Otonomy, a portfolio company of RiverVest Venture Partners, has launched its IPO after pricing its 6.25 million shares at $16 per share. The stock began trading Wednesday on the NASDAQ under the ticker symbol “OTIC.” Based in San Diego, Otonomy is a biopharmaceutical firm that is developing treatments for the inner and middle ear.

VTTI rolls out IPO

VTTI has launched its IPO of 17.5 million shares at $21 per share. The stock began trading Friday on the NYSE under the ticker symbol “VTTI.” Citigroup, J.P. Morgan, BofA Merrill Lynch, Credit Suisse, Deutsche Bank Securities and Wells Fargo Securities are the lead underwriters. VTTI is a limited partnership that owns, develops and acquires refined petroleum product and crude oil terminaling and related energy infrastructure assets.

106 Views

PE-backed surgical implants maker Innocoll debuts IPO

Innocoll AG has launched its IPO after pricing its 6.5 million shares at $9 per share. The stock began trading Friday on the NASDAQ under the ticker symbol “INNL.” Piper Jaffray and Stifel were the lead underwriters. Based in Ireland, Innocoll is a pharmaceutical firm that develops surgical implants. Its backers include Cam Investment, Morgan Stanley, NewSmith Opportunities Private Equity Fund and ACL Investments.

PEHUB Community

Join the 12501 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget

Marketplace

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget